Edward White

Edward White has a diverse and extensive work experience in the field of equity research and analysis. Edward started their career as an Equity Research Associate at Fahnestock and Company in 1996, before moving to BMO Capital Markets as an Associate Equity Research for Pharmaceuticals in 1997. Edward then joined Deutsche Bank Securities as an Equity Research Associate in 1998. In 2003, they became a Vice President/Healthcare Equity Analyst at Mitsubishi UFJ Trust and Banking, where they managed over $1.3 billion in healthcare investments. Edward later worked as a Director and Senior Med Tech/Supply Equity Analyst at Murphy & Durieu from 2010 to 2012. From 2012 to 2014, they served as a Senior Managing Director and Healthcare Equity Analyst at a Small Retail Focused Investment Bank and Brokerage. Edward then moved to FBR in 2015, where they held the position of Senior Vice President/Senior Biotechnology Analyst until 2017. Currently, Edward White is working as a Managing Director and Senior Biotechnology Analyst at H.C. Wainwright & Co., LLC.

Edward White has a diverse education history. Edward first attended LaSalle Institute for an unspecified period, providing no specific information regarding the degree or field of study. Later, from 1986 to 1990, they pursued a Bachelor of Science (BS) degree in Biology at Manhattan College. Subsequently, from 1990 to 1992, Edward attended the Icahn School of Medicine at Mount Sinai, although no degree name is provided for this period. Finally, they completed a Master of Business Administration (MBA) degree in Finance from the Rensselaer Polytechnic Institute - The Lally School of Management between 1994 and 1996. Additionally, Edward obtained certifications in Series 7, 63, 86, and 87 from the Financial Industry Regulatory Authority (FINRA), although the specific dates of completion are not provided.